Identification of prognostic subgroups among acute myeloid leukemia patients with intermediate risk cytogenetics using a flow-cytometry-based assessment of ABC-transporter function
Keywords: Allo-SCT; allogeneic stem cell transplantation; AML; acute myeloid leukemia; BCRP; Breast Cancer Resistance Protein; BM; bone marrow; CEBPA; CCAAT/enhancer binding protein alpha; CR; complete remission; DFS; disease free survival; DNR; daunorubicin; FLT3